Oregon
The Board of Pharmacy posted an agenda for the Compounding Workgroup meeting scheduled to be held on June 20. See link below
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Oregon
The June 7-9, 2023 Board of Pharmacy Meeting agenda and meeting materials are now available. Additional meeting materials may be added to the agenda prior to the board meeting. Visit the board website for current meeting materials.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Oregon
The Oregon Health Authority Public Health Division (OHA-PHD) announced a public hearing via Zoom on OHA-PHD’s proposal for the use of funds from the Preventive Health and Health Services Block Grant on May 31 from 1:00 p.m.-1:30 p.m. The draft proposal will be posted at www.healthoregon.org/lhd prior to the meeting. Program contact is Sara Beaudrault.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Oregon
The Oregon Health Authority and the Oregon Department of Human Services announced lifting of COVID-19 response measures as federal health emergency ended. Some changes were effective May 11 while others will take effect in the coming weeks.
Also in Oregon, the Board of Pharmacy posted the agenda for the May 16 meeting of the Compounding Workgroup and the agenda for the May 17 meeting of the Public Health & Formulary Advisory Committee.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Oregon
The Oregon Health Authority issued a meeting notice for the Immunization Policy Advisory Team on June 1 from 12:00 noon to 2:00 p.m. The meeting will be conducted via Zoom and requires registration in advance using this link. Registrants will receive a confirmation email with additional information to join the meeting. The draft agenda appears below and the final agenda will be available by sending an email request to imm.info@oha.oregon.gov three days before the meeting date. It will also be available during the Zoom meeting. See additional details in the notice below.
Agenda: Draft items include:
- Public comment
- Athletes and COVID-19 vaccine
- Immunization uptake
- Data analysis – small numbers policy
- 2022 population-based rates for 2-year-olds
- 2023 school immunization update
- COVID-19 vaccine and therapeutics commercialization
- COVID-19 vaccine updates
Also in Oregon, the Oregon Health Authority published a Notice of Proposed Rule Making amending Prior Authorization Approval Criteria Guide & Preferred Drug List DUR/P&T Actions. Written comments may be sent to hsd.rule@odhsoha.state.or.us no later than 5:00 p.m. on June 21.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Oregon
The Department of Human Services began issuing $170 million in Pandemic EBT (P-EBT) food benefits to 434,000 students and young children in late March through May. These additional food benefits are part of the Pandemic EBT (P-EBT) program, a temporary COVID-19 response program meant to provide additional food support for children whose access to food provided through school programs may have been impacted by COVID-19. A P-EBT card containing $391 in food benefits, which is different from a regular electronic benefit transfer (EBT) card, will be sent by mail to each eligible child.
Also in Oregon, the Oregon Health Authority published a final rule effective April 1, amending Prior Authorization Approval Criteria Guide & Preferred Drug List DUR/P&T Actions. (OAR 410-121-0030, OAR 410-121-0040)
Also in Oregon, the Board of Pharmacy published a final rule effective April 4, amending Committee Member Compensation. (OAR 855-010-0016)
Also in Oregon, the Board of Pharmacy posted the following:
- Interns Workgroup – May 3 at 1:00 p.m. – Agenda
- Collaborative Drug Therapy Management / Clinical Pharmacy Agreements Workgroup – May 4 at 1:00 p.m. — Agenda and Meeting Materials
Also in Oregon, the Board of Pharmacy is proposing to adopt the following rules and announced a May 23 public hearing. Written comments may be sent to pharmacy.rulemaking@bop.oregon.gov no later than 4:30 p.m. on May 23.
- Divisions 006/041/043/045/080/139/141 related to Adopted Standards by Reference
- Divisions 019/020 related to Pharmacist Prescriptive Authority
- COVID-19 Monoclonal Antibody & COVID-19 Antiviral Protocols *Repeal
- Continuation of therapy including emergency refills of insulin v. 06/2023
Travel Medications v. 06/2023 - HIV (Human Immunodeficiency Virus) Post-exposure Prophylaxis (PEP) v. 06/2023
HIV Pre-exposure Prophylaxis (PrEP) v. 06/2023 - Contraception v. 06/2023
Finally in Oregon, the Board of Pharmacy adopted the following Temporary Rule, effective May 5: Division 045 – related to USP <795> and USP <797> Adopted Standards by Reference
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Oregon
The Board of Pharmacy posted the agenda and meeting materials for the next Board Meeting scheduled for April 12-14; see additional details below. Also, please note the following agenda item:
- Div 019/020- Pharmacist Prescriptive Authority – COVID-19 Monoclonal Antibody, COVID-19 Antiviral, Continuation of Therapy including emergency refills of insulin, Contraception, PEP, PrEP, Travel Medications Protocols- #A2, A2a, A2b, A2c, A2d, A2e. See pp 47-103 (inclusive) of the PDF.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Oregon
SB 1085, legislation permitting pharmacists to test and treat for certain health conditions, requiring payment for pharmacist services and allowing pharmacists to delegate to a pharmacy technician or intern to perform testing under the pharmacist's supervision, is scheduled for a hearing in the Senate Committee on Health Care on March 29. The health conditions include influenza; lice; COVID-19 or other respiratory conditions, diseases, or illnesses; skin conditions, such as athlete's foot or ringworm; streptococcus; urinary tract infection; other health conditions identified by the Oregon Health Authority as a public health emergency or other health conditions as identified by the Board of pharmacy by rule for which a patient may be tested.
Also in Oregon, the Board of Pharmacy is seeking subject matter experts to serve on a workgroup concerning Collaborative Drug Therapy Management (CDTMs) and Clinical Pharmacy Agreement (CPAs). The purpose of this workgroup is to gather information related to CDTMs and CPAs and provide input for rules to ensure patient health, safety and welfare. It is anticipated that the workgroup will provide input on development of updated rules and provide the Board with recommendations, insights, and input on proposed rules. See additional information below. If you would like to serve on the CDTM/CPA workgroup, please complete the online form by Friday April 7, 2023. Those that are selected will receive confirmation by Friday April 14, 2023.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Oregon
Dana Hittle has been appointed as the permanent Medicaid director and will oversee Oregon’s Medicaid program, including the Oregon Health Plan. Hittle previously served as interim state Medicaid director for the last two years and, before that, was deputy Medicaid director.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.